Urokinase-Type Plasminogen Activator and Its Inhibitor Type 1 Predict Disease Outcome and Therapy Response in Primary Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference20 articles.
1. The urokinase-type plasminogen activator system in cancer metastasis: a review;Andreasen;Int J Cancer,1997
2. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy;Schmitt;Thromb Haemost,1997
3. Clinical utility of uPA/PAI-1 determination in primary breast cancer tissue for individualized therapy concepts;Harbeck;Clin Breast Cancer,2002
4. External quality assessment of trans-European multicentre antigen determinations (ELISA) of urokinase-type plasminogen activator (uPA) and its type-1 inhibitor (PAI-1) in human breast cancer tissue extracts;Sweep;Br J Cancer,1998
5. Pooled analysis of prognostic impact of uPA and PAI-1 in 8,377 breast cancer patients;Look;J Natl Cancer Inst,2002
Cited by 86 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Plg-RKT Expression in Human Breast Cancer Tissues;Biomolecules;2022-03-26
2. Beyond Chemotherapies: Recent Strategies in Breast Cancer Treatment;Cancers;2020-09-16
3. A review of clinical and emerging biomarkers for breast cancers: towards precision medicine for patients;Journal of Radiotherapy in Practice;2020-09-11
4. A Brief Overview of the Paradoxical Role of Glucocorticoids in Breast Cancer;Breast Cancer: Basic and Clinical Research;2020-01
5. The multifaceted roles of tumor-associated proteases and harnessing their activity for prodrug activation;Biological Chemistry;2019-07-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3